Nanotechnology
Life Sciences company announces research findings about nanobacteria
Published in Health and Medicine Week, August 15th, 2005
The company also announced new business initiatives that will leverage Nanobac's growing intellectual property estate to take advantage of diagnostic and therapeutic opportunities.
Since 1988 researchers at Nanobac Life Sciences, Inc., have been studying a pathogen that they believe is responsible for numerous chronic diseases affecting humankind. They called this pathogen nanobacteria because of its small size, roughly 100 billionths of a meter, and because of its ability to replicate or propagate.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
More Articles from Health and Medicine Week
- Asthma
The incidence of adult asthma appears to be increasing - Cocaine Vaccine
Glyceride adjuvant induces protective antibodies against cocaine - Immunotherapy
Recommendations on financing vaccines in 21st century presented - AIDS-Related Emphysema
AIDS-related emphysema partly due to direct alveolar macrophage HIV-1 infection - Acetylcholine Receptors
Thymic toll-like receptor studied, increase in myasthenic patients shown - Acinetobacter Baumannii Outbreak
Carbapenem-resistant Acinetobacter baumannii cause of hospital outbreak - More from this issue of Health and Medicine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
